A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina | NEJM
Original Article from The New England Journal of Medicine — A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina
Original Article from The New England Journal of Medicine — A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina
Learn about the clinical implementation of GLP-1 receptor agonists with Dr. Neha Pagidipati. Gain practical insights for medical practice.
Nature – Scientists identify the brain cells that regulate inflammation, and pinpoint how they keep tabs on the immune response.
To the Editor: In the case series presented by Müller et al. (Feb. 22 issue),1 CD19-targeting chimeric antigen receptor (CAR) T-cell therapy in patients with…
The last time you went to the emergency room or to a doctor’s office, were you surprised to be seen by a Nurse Practitioner or…
Since 1974 substantial gains in childhood survival have occurred in every global region. We estimate that EPI has provided the single greatest contribution to improved…
Perspective from The New England Journal of Medicine — The New USPSTF Mammography Recommendations — A Dissenting View
A molecular clock network is crucial for daily physiology and maintaining organismal health. We examined the interactions and importance of intratissue clock networks in muscle…
Congenital thrombotic thrombocytopenic purpura (TTP) results from severe hereditary deficiency of ADAMTS13. The efficacy and safety of recombinant ADAMTS13 and standard therapy (plasma-derived prod…
Congenital thrombotic thrombocytopenic purpura (TTP) results from severe hereditary deficiency of ADAMTS13. The efficacy and safety of recombinant ADAMTS13 and standard therapy (plasma-derived prod…
A 47-year-old man presented with 2-day history of weakness and fever. Laboratory studies showed pancytopenia. A bone marrow biopsy showed promyelocytes with abundant intracellular rods.